The present study investigated the clinical significance of active SRC expression in HNSCC patients, by means of immunohistochemical detection with Clone 28 antibody specifically recognizing the active form of SRC [35,47]. The gene discussed is SRC; the disease is head and neck squamous cell carcinoma.